Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.43B |
| 3 |
Boeing
BA
|
+$283M |
| 4 |
CrowdStrike
CRWD
|
+$251M |
| 5 |
Coinbase
COIN
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$845M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$837M |
| 3 |
Broadcom
AVGO
|
+$691M |
| 4 |
NVIDIA
NVDA
|
+$662M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$660M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 93.75% |
| 2 | Technology | 1.85% |
| 3 | Consumer Discretionary | 1.02% |
| 4 | Financials | 0.76% |
| 5 | Communication Services | 0.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11651
CALL
Fusion Fuel Green
HTOO
$14.2M
| $11.8K | ﹤0.01% |
660
+23
| +4% | +$574 |
|
|
AGPU
11652
Axe Compute Inc
AGPU
$120M
| $11.8K | ﹤0.01% |
997
+90
| +10% | +$1.34K |
|
|
TRIB
11653
PUT
Trinity Biotech
TRIB
$7.93M
| $11.8K | ﹤0.01% |
+357
| New | +$24.1K |
|
11654
Vivani Medical
VANI
$126M
| $11.7K | ﹤0.01% |
10,022
-320
| -3% | -$400 |
|
|
GRI
11655
GRI Bio
GRI
$4.53M
| $11.7K | ﹤0.01% |
+68
| New | +$27.4K |
|
11656
MarketWise
MKTW
$49.8M
| $11.6K | ﹤0.01% |
+868
| New | +$15.9K |
|
11657
Biomerica
BMRA
$6.49M
| $11.3K | ﹤0.01% |
4,311
-8,407
| -66% | -$24.1K |
|
11658
Revelation Biosciences
REVB
$4.1M
| $11.3K | ﹤0.01% |
+69
| New | +$16.6K |
|
|
STLN
11659
Starling Oncology
STLN
$646M
| $11.2K | ﹤0.01% |
34,411
+3,229
| +10% | +$1.34K |
|
11660
Ryde Group
RYDE
$116M
| $11.1K | ﹤0.01% |
+14,304
| New | +$98.5K |
|
11661
PUT
Coherus Oncology
CHRS
$226M
| $11K | ﹤0.01% |
10,600
-38,500
| -78% | -$52.8K |
|
|
ALLK
11662
CALL
DELISTED
Allakos
ALLK
| $10.9K | ﹤0.01% |
16,800
+2,200
| +15% | +$1.59K |
|
11663
Inno Holdings
INHD
$15.1M
| $10.7K | ﹤0.01% |
+4
| New | +$11.1K |
|
|
CISO
11664
CISO Global
CISO
$10.2M
| $10.5K | ﹤0.01% |
15,008
+2
| +0% | +$1 |
|
11665
PUT
Quantum-Si Incorporated
QSI
$176M
| $10.5K | ﹤0.01% |
11,900
-800
| -6% | -$777 |
|
11666
Solana Company
HSDT
$147M
| $10.2K | ﹤0.01% |
24
+2
| +9% | +$1.19K |
|
11667
Future FinTech Group
FTFT
$18.8M
| $10.2K | ﹤0.01% |
169
+98
| +138% | +$5.76K |
|
11668
PUT
Comstock
LODE
$271M
| $10.2K | ﹤0.01% |
+2,160
| New | +$4.98K |
|
11669
AgEagle Aerial Systems
UAVS
$70.5M
| $9.97K | ﹤0.01% |
2,119
-1,144
| -35% | -$21.5K |
|
11670
Lineage Cell Therapeutics
LCTX
$293M
| $9.96K | ﹤0.01% |
10,996
-60,326
| -85% | -$55.9K |
|
|
11671
PUT
Fusion Fuel Green
HTOO
$14.2M
| $9.95K | ﹤0.01% |
557
-234
| -30% | -$5.84K |
|
|
HEPA
11672
DELISTED
Hepion Pharmaceuticals
HEPA
| $9.81K | ﹤0.01% |
293
| – | – |
|
11673
TH International
THCH
$40.7M
| $9.79K | ﹤0.01% |
+2,417
| New | +$8.1K |
|
|
KZR
11674
DELISTED
Kezar Life Sciences
KZR
| $9.74K | ﹤0.01% |
1,259
-27,713
| -96% | -$167K |
|
|
HYPD
11675
PUT
Hyperion DeFi Inc
HYPD
$56.3M
| $9.72K | ﹤0.01% |
+234
| New | +$15.1K |
|
Similar funds
Jeff Yass's Q3 2024 Portfolio in Review
As of Q3 2024, Jeff Yass held 13,475 positions worth $572B, up 6.6% from $537B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Jeff Yass's Q3 2024 filing shows 1,572 new, 5,247 increased, 4,924 reduced and 1,625 closed positions. Its largest new stake was Camtek: 408,771 shares worth $32.6M. The largest sale was Apple, an estimated $845M.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q3 2024 buy was Camtek: 408,771 shares worth $32.6M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $2.58B increase.
- Jeff Yass's biggest Q3 2024 reduction was Apple, cutting an estimated $845M.
- Jeff Yass fully exited iShares Convertible Bond ETF in Q3 2024, selling an estimated $80.5M.
- Jeff Yass's ten largest holdings make up 25% of its $572B portfolio in Q3 2024.
- Jeff Yass opened 1,572 new positions and closed 1,625 in Q3 2024.
- Jeff Yass's portfolio value rose 6.6% quarter-over-quarter to $572B.
Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.